WTC workers exposed earlier to dust cloud have higher risk of atherosclerotic lesions

November 17, 2011

In the first study using magnetic resonance imaging (MRI) to evaluate cardiovascular risk in World Trade Center (WTC) first responders, researchers from Mount Sinai School of Medicine have found that the responders who experienced high levels of exposure to the initial dust cloud on September 11, 2001, demonstrate high-risk features of atherosclerosis (plaque in arteries). The data were presented at the American Heart Association's Scientific Sessions 2011 in Orlando, Florida.

Mary Ann McLaughlin, MD, MPH, Associate Professor of Medicine is the primary investigator for this study and has been evaluating the cardiovascular health of the WTC responders since 2007. In addition to the current study, her research has shown more impaired cardiac relaxation and coronary calcification in responders at Ground Zero, compared with the general population.

First author, Venkatesh Mani, PhD, and colleagues, used MRI to evaluate the blood vessels of 19 responders exposed to the high levels of particulate matter from the dust cloud, and 12 exposed to the lower levels. They found that WTC workers who were exposed to the initial dust cloud had higher blood vessel formation in their artery plaque compared to people with lower exposure. Co-investigator, Simonette Sawit, MD also demonstrated impaired vascular reactivity, or dysfunction of the inner lining of blood vessels, in those with higher dust exposure. This dysfunction may accelerate the progression of atherosclerosis. The Mount Sinai team discovered this association in WTC workers independent of other clinical factors.

"Using noninvasive MRI imaging, we were able to see a significant impact of the events of 9/11 on the cardiovascular health of the brave men and women who responded that day," said Zahi Fayad, PhD, Professor of Radiology, and Medicine in the Division of Cardiology, and the Director of the Translational and Molecular Imaging Institute at Mount Sinai School of Medicine. "Now that we have visualized the risk and early development of vascular lesions, in a subset of subjects, we look forward to studying the use of imaging in the greater patient population."

"This study defines physiologic change associated with greater exposure to the dust cloud at the WTC site," said Dr. McLaughlin. "We are currently evaluating other predictors of cardiovascular risk in this population to gain a better understanding of the impact of particulate matter exposure on cardiovascular health."

The Mount Sinai Hospital / Mount Sinai School of Medicine

---

---

	Dyslipidemia and Atherosclerosis Essentials 2009 by Christie M. Ballantyne (Author), James H. O'Keefe Jr. (Author), Antonio M. Gotto Jr. (Author) The World's Leading Experts Provide all the 'Essentials' Needed to Manage Patients in the Office, on the Ward, and in the Intensive Care Unit! Written by key opinion leaders in the field of cardiology, Dyslipidemia Essentials integrates the latest clinical guidelines and trials into a practical step-by-step guide to the management of dyslipidemia. Important clinical trials, common management pitfalls, and other cardiovascular risk reduction measures are also emphasized. Topics include: Step-by-step guide to intensive LDL lowering; NCEP ATP III and AHA/ACC guideline Updates; Treatment of low HDL cholesterol and elevated triglyceride; 73 dyslipidemia trials and 17 drug summaries
	CATHETER-BASED TREATMENT OF ATHEROSCLEROSIS: Options for effective percutaneous intervention are plentiful From the initial balloon catheters, percutaneous ... protection devices. (Postgraduate Medicine) by JTE Multimedia Hopes for successful utilization, minimal complications, and improved patient comfort ride on interventional cardiology. A variety of devices are available or in development for percutaneous treatment of atherosclerotic disease. Here, Dr Khalil reviews devices with a long history in cardiology as well as newer arrivals and discusses their best-use parameters and appropriate application. He also summarizes the outcome data on their use. Original Publication Date: March 2004
	C-REACTIVE PROTEIN AS A NOVEL BIOMARKER: Reactant can flag atherosclerosis and help predict cardiac events Exploring the role of this acute phase response ... disease. (Postgraduate Medicine) by JTE Multimedia C-reactive protein (CRP) is a relatively nonspecific marker of inflammation. However, it can be used to monitor the severity and progression of some well-defined cardiovascular diseases. For example, it can predict serious events in patients with coronary artery disease (CAD) who are hospitalized with acute coronary syndrome, myocardial infarction (MI), or advanced peripheral vascular disease. In this article, the authors review the role of CRP in the diagnosis, monitoring, and treatment of various forms of ischemic and inflammatory cardiovascular disease. Original Publication Date: December 2003
	Oophorectomy Increases Risk for Atherosclerosis.(Brief Article): An article from: Family Practice News by Doug Brunk (Author) This digital document is an article from Family Practice News, published by International Medical News Group on February 1, 2001. The length of the article is 348 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Oophorectomy Increases Risk for Atherosclerosis.(Brief Article) Author: Doug Brunk Publication: Family Practice News (Magazine/Journal) Date: February 1, 2001 Publisher: International Medical News Group Volume: 31 Issue: 3 Page: 25 Article Type: Brief Article Distributed by Thomson...
	Metabolic syndrome predicts subclinical atherosclerosis in adults.(Across Specialties): An article from: Clinical Psychiatry News by Bruce Jancin (Author) This digital document is an article from Clinical Psychiatry News, published by Thomson Gale on July 1, 2005. The length of the article is 539 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Metabolic syndrome predicts subclinical atherosclerosis in adults.(Across Specialties) Author: Bruce Jancin Publication: Clinical Psychiatry News (Magazine/Journal) Date: July 1, 2005 Publisher: Thomson Gale Volume: 33 Issue: 7 Page: 59(1) Distributed by Thomson...
	METEOR Trial Reports on the Effect of Rosuvastatin on Progression of Carotid Intima-Media Thickness in Low-Risk Individuals with Subclinical Atherosclerosis (The Physician and Sportsmedicine) by JTE Multimedia PRACTICE PEARL The data from the METEOR trial show that asymptomatic low-risk patients treated with rosuvastatin have a reduction in progression of carotid intima-media thickness (CIMT) over 2 years versus placebo. Original Article Crouse JR 3rd, Raichlen JS, Riley WA, et al; METEOR Study Group. Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial. JAMA. 2007;297(12):1344–1353.
	Asymptomatic Atherosclerosis: Pathophysiology, Detection and Treatment (Contemporary Cardiology) by Morteza Naghavi (Editor) Despite recent advances in the diagnosis and treatment of symptomatic atherosclerosis, available traditional screening methods for early detection and treatment of asymptomatic coronary artery disease are grossly insufficient and fail to identify the majority of victims prior to the onset of a life-threatening event. In Asymptomatic Atherosclerosis: Pathophysiology, Detection and Treatment, Dr. Morteza Naghavi and leading authorities from the Society for Heart Attack Prevention and Eradication (SHAPE) present a new paradigm for the screening and primary prevention of asymptomatic atherosclerosis. The text focuses on accurate, yet underutilized, measures of subclinical atherosclerosis, notably coronary artery calcium scanning and carotid intima-media thickness measurement. The authors...
	Atlas of Atherosclerosis Progression and Regression, Second Edition (Encyclopedia of Visual Medicine Series) by Herbert C. Stary (Author) This book illustrates the successive steps in the natural history of human atherosclerotic disease from the microscopically visible, lipid-filled macrophages in susceptible locations of arteries to lesion forms that produce clinical symptoms. The book clarifies disputed issues such as the morphological features already present in the arteries of children and their relationship, if any, to later symptom-producing lesions. The illustrations allow readers to compare and contrast healthy arteries with those developing and regressing lesions. In addition to light and electron micrographs, there are photographs of opened arteries to reveal atherosclerotic lesions as seen with unaided eye.
	Atherosclerosis Risk Factors by James J. Maciejko (Author) Atherosclerosis Risk Factors provides practitioners, laboratorians, and researchers with information about specific characteristics -- called risk factors -- that may be predictive of the development of atherosclerosis. It examines the evidence demonstrating that changing these risk factors impacts the subsequent risk of progression. In essence, the aim of the book is to provide the reader with insight regarding which biochemical atherosclerosis risk factors provide clinically relevant information that will assist the clinician medically -- rather than anatomically -- preventing, arresting, or reversing this disease process, particularly in the coronary arteries. The book also addresses the vascular biology of atherosclerosis and the epidemiologic and analytical criteria for establishing...
	Atherosclerosis by Sarah Jane George (Editor), Jason Johnson (Editor) Covering the most devastating disease in the Western world, this handbook and ready reference provides a comprehensive account of the different stages and factors in the development of the atherosclerotic plaque. Each chapter is written by experts in the field and highlights the role of specific mediators of atherosclerotic plaque development, as well as potential therapeutic targets. A large amount of this up-to-date information is conveyed by way of tables and schematic figures, in a readily comprehensible manner. A must-have for master and PhD students, researchers, MDs and lecturers in vascular biology and cardiology, as well as for academics and scientists in the pharmaceutical industry.